Read the original here:
Eyenovia Reports Fourth Quarter 2022 Financial Results and Provides Business Update
Category Archives: Global News Feed
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Phase 2 LUNA Trial Update
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
Read the original here:
Allogene Therapeutics Announces Participation in Two Upcoming Investor Conferences
Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced…
Number of voting rights as of January 9, 2023
Continued here:
Number of voting rights as of January 9, 2023
NGM Bio Outlines Corporate Strategy and Provides Guidance on Key Priorities
PMV Pharmaceuticals Appoints Industry Veteran Dr. Carol Gallagher to Board of Directors
FDA approves Roche’s Lunsumio, a first-in-class bispecific antibody, to treat people with relapsed or refractory follicular lymphoma
Immutep Receives A$2.7 million R&D Tax Incentive from French Government
Follow this link:
Immutep Receives A$2.7 million R&D Tax Incentive from French Government
Adverum Biotechnologies Announces Upcoming Data Presentation at AAO 2022
Continue reading here:
Adverum Biotechnologies Announces Upcoming Data Presentation at AAO 2022
Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit
Alimera Announces Agreement with Jaeb Center for Health Research on Behalf of the DRCR Retina Network
Jasper Therapeutics to Present at Upcoming Conferences
Original post:
Jasper Therapeutics to Present at Upcoming Conferences
Allogene Therapeutics Announces Participation in the Jefferies Cell and Genetic Medicine Summit
Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS)
Oncternal Therapeutics to Participate in the Cantor Oncology, Hematology & HemeOnc Conference
Read the original here:
Oncternal Therapeutics to Participate in the Cantor Oncology, Hematology & HemeOnc Conference